WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn’t adapt fast enough to a rapidly changing weight-loss environment spurred by the rising popularity of GLP-1s, experts said. The post Why WeightWatchers Filed for Bankruptcy appeared first on MedCity News.
As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board. The post…
As demand for trial sites increases, more investigators are overburdened or experiencing burnout. What can the industry do to help? The post Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it appeared first on MedCity News.
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the FDA’s phasing out of fluoride drops and tablets for children on CBS’ “CBS Mornings” on May 15. Click here to watch Gounder on “CBS Mornings.” KFF Health News Southern correspondent Sam Whitehead discussed what Medicaid cuts could mean for Georgia on The Atlanta Journal-Constitution’s “Politically…
Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value. The post Don’t Let the Floor Fall Out From Under…
Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The post Sprinter Health Raises $55M to Expand Home Health Services for Health Plans appeared first on MedCity News.
Lakdawalla and Goldman.Tyler Cowen.AARP.National Pharmaceutical Council (from 2021)BIO.Adam FeinHere is a comparison of the CMS Final Rule (from 2021) vs. 2025 Trump Executive Order.
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
Uncertainty around federal efforts to expand high-speed internet — and with it telehealth access — to all Americans swirled fast this week after President Donald Trump vowed to end what he called the “racist” and “unconstitutional” Digital Equity Act. The act is part of the $1.2 trillion Infrastructure Investment and Jobs Act of 2021, which…
Based on draft reconciliation language from the Energy & Commerce Committee, the Congressional Budget Office (CBO) released preliminary estimates showing proposed Medicaid changes would reduce federal Medicaid spending by $625 billion. Building on earlier KFF analysis, this analysis puts this magnitude of federal funding cuts into context by showing how the cuts relate to states’…